These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 6131064)

  • 21. [Antidepressant treatment of schizophrenic patients].
    Caroli F; Baldacci-Epinette C; Ribeyre P
    Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-psychotic depression in schizophrenia.
    Jeczmien P; Levkovitz Y; Weizman A; Carmel Z
    Isr Med Assoc J; 2001 Aug; 3(8):589-92. PubMed ID: 11519384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 24. Which tricyclic for depressed outpatients, imipramine pamoate or amitriptyline?
    Goldberg HL; Finnerty RJ
    Dis Nerv Syst; 1977 Oct; 38(10):785-9. PubMed ID: 332472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs)].
    Beresewicz M; Bidzińska E; Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):13-8. PubMed ID: 1687987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance, evaluation, and management of secondary depression in schizophrenia.
    Becker RE; Singh MM; Meisler N; Shillcutt S
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):26-32. PubMed ID: 2865254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of antidepressants for negative symptoms in a subset of schizophrenic patients.
    Siris SG; Bermanzohn PC; Gonzalez A; Mason SE; White CV; Shuwall MA
    Psychopharmacol Bull; 1991; 27(3):331-5. PubMed ID: 1775607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance imipramine treatment following postpsychotic depression.
    Siris SG; Cutler J; Owen K; Lang MP
    Psychopharmacol Bull; 1989; 25(1):85-8. PubMed ID: 2672073
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.
    Siris SG; Bermanzohn PC; Mason SE; Rifkin A; Alvir JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):539-47. PubMed ID: 1641497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 35. [Depression in schizophrenia. Comments on possibilities to use fluoxetine].
    Jarema M
    Psychiatr Pol; 1996; 30(1):75-86. PubMed ID: 8722241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of depressions in post-stroke patients.
    Balunov OA; Sadov OG; Alemasova AYu
    Alaska Med; 1990; 32(1):20-9. PubMed ID: 2353741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression.
    Siris SG; Adan F; Strahan A; Aronson A; Mandeli J; Fasano-Dube B
    Compr Psychiatry; 1989; 30(6):483-8. PubMed ID: 2582754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
    Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.